Receptos, Inc. (RCPT) Files $86.3M IPO

Receptos, Inc. (Nasdaq: RCPT) filed a registration with the U.S. Securities and Exchange Commission for an Initial Public Offering of its Common Stock. The proposed maximum offering price is $86.3 million. Receptos plans to list on the NASDAQ Global Market under the symbol "RCPT."

The offering is being made through Credit Suisse, Leerink Swann, BMO Capital Markets, and Wedbush PacGrow Life Sciences.

Receptos is a biopharmaceutical company focused on discovering, developing and commercializing innovative therapeutics for immune disorders.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• B&R Technology Merger Corp. prices $325M IPO on Nasdaq
• Sunshine Biopharma sets up $4M at-the-market stock offering
• BMO Capital Starts Insmed (INSM) at Outperform